Preparing for Renal Replacement Therapy in Patients with the Ebola Virus Disease
The Ebola virus disease (EVD) is a serious illness characterized by fever, severe vomiting and diarrhea, and, in severe cases, multi-organ failure requiring mechanical ventilation and renal replacement therapy. The current outbreak has centered in West Africa and affected over 15,000 individuals. EVD is transmitted by direct contact with blood or other infectious bodily fluid, and as such, numerous heath care workers caring for patients with EVD have become infected. During the current outbreak, a number of patients have received advanced supportive care for EVD in Europe and North America and therefore survived. Now, many hospitals in Europe and North America are planning to accept care for patients with EVD. In this review, we discussed the key issues related to the planning and delivery of advanced supportive care in patients with EVD with a focus on the factors necessary to provide renal replacement therapy (RRT). Since success in the treatment of patients with EVD rests on both patient outcome and prevention of transmission of disease to health care workers, we extensively discussed the modes of Ebola virus transmission and recommended protocols to protect health care workers. Experience now indicates that with appropriate planning and protocols, it is possible to successfully treat EVD patients with advanced supportive care (mechanical ventilation and RRT) while avoiding transmission to health care providers. Video Journal Club "Cappuccino with Claudio Ronco" at http://www.karger.com/?doi=371530. © 2015 S. Karger AG, Basel.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
Blood purification - 38(2015), 3-4, Seite 276-285 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Faubel, Sarah [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.1159/000371530 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC195652701X |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC195652701X | ||
| 003 | DE-627 | ||
| 005 | 20230516102837.0 | ||
| 007 | tu | ||
| 008 | 160206s2015 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1159/000371530 |2 doi | |
| 028 | 5 | 2 | |a PQ20160617 |
| 035 | |a (DE-627)OLC195652701X | ||
| 035 | |a (DE-599)GBVOLC195652701X | ||
| 035 | |a (PRQ)c1488-1ae3f2969e9291be0c9d00f7241491e017b883ec8672b7e2d55988a544d00cbf0 | ||
| 035 | |a (KEY)0120736920150000038000300276preparingforrenalreplacementtherapyinpatientswitht | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 084 | |a 44.00 |2 bkl | ||
| 100 | 1 | |a Faubel, Sarah |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Preparing for Renal Replacement Therapy in Patients with the Ebola Virus Disease |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a The Ebola virus disease (EVD) is a serious illness characterized by fever, severe vomiting and diarrhea, and, in severe cases, multi-organ failure requiring mechanical ventilation and renal replacement therapy. The current outbreak has centered in West Africa and affected over 15,000 individuals. EVD is transmitted by direct contact with blood or other infectious bodily fluid, and as such, numerous heath care workers caring for patients with EVD have become infected. During the current outbreak, a number of patients have received advanced supportive care for EVD in Europe and North America and therefore survived. Now, many hospitals in Europe and North America are planning to accept care for patients with EVD. In this review, we discussed the key issues related to the planning and delivery of advanced supportive care in patients with EVD with a focus on the factors necessary to provide renal replacement therapy (RRT). Since success in the treatment of patients with EVD rests on both patient outcome and prevention of transmission of disease to health care workers, we extensively discussed the modes of Ebola virus transmission and recommended protocols to protect health care workers. Experience now indicates that with appropriate planning and protocols, it is possible to successfully treat EVD patients with advanced supportive care (mechanical ventilation and RRT) while avoiding transmission to health care providers. Video Journal Club "Cappuccino with Claudio Ronco" at http://www.karger.com/?doi=371530. © 2015 S. Karger AG, Basel | ||
| 540 | |a Nutzungsrecht: © 2014 by S. Karger AG, Basel | ||
| 540 | |a © 2015 S. Karger AG, Basel. | ||
| 650 | 4 | |a Biocontainment facility | |
| 650 | 4 | |a Ebola virus disease | |
| 650 | 4 | |a Renal replacement therapy | |
| 650 | 4 | |a Patient Care Team - ethics | |
| 650 | 4 | |a Acute Kidney Injury - diagnosis | |
| 650 | 4 | |a Systemic Inflammatory Response Syndrome - etiology | |
| 650 | 4 | |a Water-Electrolyte Imbalance - etiology | |
| 650 | 4 | |a Body Fluids - virology | |
| 650 | 4 | |a Acute Kidney Injury - etiology | |
| 650 | 4 | |a Renal Replacement Therapy - instrumentation | |
| 650 | 4 | |a Ebolavirus - isolation & purification | |
| 650 | 4 | |a Infectious Disease Transmission, Patient-to-Professional - prevention & control | |
| 650 | 4 | |a Acute Kidney Injury - therapy | |
| 650 | 4 | |a Containment of Biohazards - instrumentation | |
| 650 | 4 | |a Water-Electrolyte Imbalance - therapy | |
| 650 | 4 | |a Hemorrhagic Fever, Ebola - prevention & control | |
| 650 | 4 | |a Kidney Tubular Necrosis, Acute - etiology | |
| 650 | 4 | |a Ebolavirus - pathogenicity | |
| 650 | 4 | |a Anticoagulants - adverse effects | |
| 650 | 4 | |a Critical Care - methods | |
| 650 | 4 | |a Containment of Biohazards - methods | |
| 650 | 4 | |a Hemorrhagic Fever, Ebola - transmission | |
| 650 | 4 | |a Hemorrhagic Fever, Ebola - complications | |
| 650 | 4 | |a Patient Isolation - instrumentation | |
| 650 | 4 | |a Renal Replacement Therapy - methods | |
| 650 | 4 | |a Hemorrhagic Fever, Ebola - therapy | |
| 650 | 4 | |a Anticoagulants - administration & dosage | |
| 650 | 4 | |a Patient Isolation - methods | |
| 650 | 4 | |a Anticoagulants - contraindications | |
| 650 | 4 | |a Disease Outbreaks - prevention & control | |
| 700 | 1 | |a Franch, Harold |4 oth | |
| 700 | 1 | |a Vijayan, Anitha |4 oth | |
| 700 | 1 | |a Barron, Michelle A |4 oth | |
| 700 | 1 | |a Heung, Michael |4 oth | |
| 700 | 1 | |a Liu, Kathleen D |4 oth | |
| 700 | 1 | |a Koyner, Jay L |4 oth | |
| 700 | 1 | |a Conner Jr, Michael J |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Blood purification |d Basel : Karger, 1983 |g 38(2015), 3-4, Seite 276-285 |w (DE-627)130402168 |w (DE-600)605548-5 |w (DE-576)038681064 |x 0253-5068 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2015 |g number:3-4 |g pages:276-285 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1159/000371530 |3 Volltext |
| 856 | 4 | 2 | |u http://www.karger.com/Article/Fulltext/371530 |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/25675963 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_2018 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.00 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 38 |j 2015 |e 3-4 |h 276-285 | ||